These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7726528

  • 1. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.
    Fung-Tomc JC, Huczko E, Stickle T, Minassian B, Kolek B, Denbleyker K, Bonner D, Kessler R.
    Antimicrob Agents Chemother; 1995 Feb; 39(2):533-8. PubMed ID: 7726528
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
    Bauernfeind A, Jungwirth R, Schweighart S, Theopold M.
    Infection; 1990 Feb; 18 Suppl 3():S155-67. PubMed ID: 2079378
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M, Browne FA, Jacobs MR, Appelbaum PC.
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.
    Biedenbach DJ, Jones RN, Erwin ME.
    J Clin Microbiol; 1993 Oct; 31(10):2828-30. PubMed ID: 8253998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
    Gerlach EH, Jones RN, Allen SD, Koontz FP, Murray PR, Pfaller MA, Washington JA, Erwin ME.
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
    Preston DA, Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The sensitivity of clinical bacteria isolated in Scotland to the oral cephalosporin, cefdinir.
    Payne DJ, Amyes SG.
    Drugs Exp Clin Res; 1992 Jun; 18(6):225-31. PubMed ID: 1478161
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B, Perry CM.
    Paediatr Drugs; 2001 Jun; 3(2):137-58. PubMed ID: 11269640
    [Abstract] [Full Text] [Related]

  • 19. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR, Benfield P.
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.